Fred Kurland Aridis Pharmaceuticals, Inc. (ARDS) insider trading activity
Fred Kurland is CFO of Aridis Pharmaceuticals, Inc.. Currently has a direct ownership of 4,000 shares of ARDS, which is worth approximately $0. The most recent transaction as insider was on Jun 05, 2023, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4K
0%
3M change
0%
12M change
Total Value Held
$0
FK
Fred Kurland
CFO
Los Gatos, CA